| Insoluble drug delivery strategies: review of recent advances and business prospects S Kalepu, V Nekkanti Acta Pharmaceutica Sinica B 5 (5), 442-453, 2015 | 1375 | 2015 |
| Solid self-microemulsifying formulation for candesartan cilexetil V Nekkanti, P Karatgi, R Prabhu, R Pillai Aaps Pharmscitech 11, 9-17, 2010 | 185 | 2010 |
| Development and characterization of solid oral dosage form incorporating candesartan nanoparticles V Nekkanti, R Pillai, V Venkateshwarlu, T Harisudhan Pharmaceutical development and technology 14 (3), 290-298, 2009 | 82 | 2009 |
| Improved delivery of poorly soluble compounds using nanoparticle technology: a review K Sandeep, N Vijaykumar Drug Delivery and Translational Research, 2016 | 73 | 2016 |
| Proliposomes for Oral Delivery: Progress and Challenges V Nekkanti, V Natarajan, G Betageri Current Pharmaceutical Biotechnology 16 (4), 1-10, 2015 | 62 | 2015 |
| Spray-drying process optimization for manufacture of drug–cyclodextrin complex powder using design of experiments V Nekkanti, T Muniyappan, P Karatgi, MS Hari, S Marella, R Pillai Drug development and industrial pharmacy 35 (10), 1219-1229, 2009 | 62 | 2009 |
| Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System V Nekkanti, Z Wang, GV Betageri AAPS PharmSciTech 17, 851-862, 2016 | 53 | 2016 |
| Recent Advances in Liposomal Drug Delivery: A Review V Nekkanti, S Kalepu Pharmaceutical Nanotechnology 3 (1), 35-55, 2015 | 53 | 2015 |
| Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine V Nekkanti, J Rueda, Z Wang, GV Betageri International journal of pharmaceutics 505 (1-2), 79-88, 2016 | 46 | 2016 |
| Topical delivery of carvedilol loaded nano-transfersomes for skin cancer chemoprevention M Chen, MA Shamim, A Shahid, S Yeung, BT Andresen, J Wang, ... Pharmaceutics 12 (12), 1151, 2020 | 44 | 2020 |
| Drug nanoparticles–An overview V Nekkanti, V Vabalaboina, R Pillai The delivery of nanoparticles, 111-132, 2012 | 37 | 2012 |
| Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics V Nekkanti, N Venkatesan, Z Wang, GV Betageri Drug development and industrial pharmacy 41 (12), 2077-2088, 2015 | 31 | 2015 |
| Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE) V Nekkanti, A Marwah, R Pillai Drug development and industrial pharmacy 41 (1), 124-130, 2015 | 27 | 2015 |
| Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes GVB Vijaykumar Nekkanti, Javier Rueda, Zhijun Wang AAPS PharmSciTech, 1-11, 2015 | 25* | 2015 |
| Development of Novel Lipid Based Drug Delivery System for Raloxifene Hydrochloride V Nekkanti, K Sandeep International Research Journal of Pharmacy 3 (9), 166-173, 2012 | 17 | 2012 |
| Insoluble drug delivery technologies: review of health benefits and business potentials B Siddalingappa, V Nekkanti, GV Betageri OA Drug Design & Delivery 1 (1), 1, 2013 | 16 | 2013 |
| Development and characterization of solid oral dosage form incorporating candesartan nanoparticles N Vijaykumar, P Raviraj, V Venkateshwarlu, T Harisudhan Pharm Dev Tech 14 (3), 290-298, 2009 | 16 | 2009 |
| Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration V Nekkanti, V Venkateswarlu, K Akhter Ansari, R Pillai Current drug delivery 8 (6), 661-666, 2011 | 11 | 2011 |
| Development of oral tablet dosage form incorporating drug nanoparticles V Nekkanti, V Venkateswarlu, R Pillai Research Journal of Pharmaceutical, Biological and Chemical Sciences 1 (4 …, 2010 | 11* | 2010 |
| Developing nanoparticle formulations of poorly soluble drugs V Nekkanti, P Karatgi, M Joshi, R Pillai Pharmaceutical Technology Europe 11, 24-28, 2008 | 10 | 2008 |
